Literature DB >> 17495858

The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function.

D P Basile1.   

Abstract

Recent evidence suggests that injury to the renal vasculature may play an important role in the pathogenesis of both early and chronic ischemic acute kidney injury (AKI). Established and new data support the suggestion that vascular injury, in particular, endothelial cell injury, participates in the extent and maintenance of AKI by pathways that are related to vascular tone. Early alterations in peritubular capillary blood flow during reperfusion has been documented and associated with loss of normal endothelial cell function, which can be replaced pharmacologically or with cell replacement interventions. Distorted peritubular capillary morphology is associated with loss of barrier function that may contribute to early alterations in vascular stasis. In addition, ischemia induces alterations in endothelial cells that may promote inflammation and procoagulant activity, thus contributing to vascular congestion. Reductions in microvasculature density may play a critical part in the progression of chronic kidney disease following initial recovery from ischemia/reperfusion-induced AKI. The exact nature of how capillary loss alters renal function and predisposes renal disease is thought to be due at least in part to hypoxia. Finally, the loss of endothelial cell function may represent an important therapeutic target in which nitric oxide, vascular trophic support, and/or endothelial progenitor cells may show potential importance in ameliorating the acute and/or chronic effects of ischemic AKI.

Entities:  

Mesh:

Year:  2007        PMID: 17495858     DOI: 10.1038/sj.ki.5002312

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  178 in total

1.  Mobilized human hematopoietic stem/progenitor cells promote kidney repair after ischemia/reperfusion injury.

Authors:  Bing Li; Amy Cohen; Thomas E Hudson; Delara Motlagh; David L Amrani; Jeremy S Duffield
Journal:  Circulation       Date:  2010-05-10       Impact factor: 29.690

2.  Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury.

Authors:  Jianlin Chen; Reji John; James A Richardson; John M Shelton; Xin J Zhou; Yanxia Wang; Qing Qing Wu; John R Hartono; Pamela D Winterberg; Christopher Y Lu
Journal:  Kidney Int       Date:  2010-10-06       Impact factor: 10.612

Review 3.  Assessment of kidney organ quality and prediction of outcome at time of transplantation.

Authors:  Thomas F Mueller; Kim Solez; Valeria Mas
Journal:  Semin Immunopathol       Date:  2011-01-28       Impact factor: 9.623

4.  Activated pericytes and the inhibition of renal vascular stability: obstacles for kidney repair.

Authors:  David P Basile; Timothy A Sutton
Journal:  J Am Soc Nephrol       Date:  2012-04-12       Impact factor: 10.121

Review 5.  Klotho as a potential biomarker and therapy for acute kidney injury.

Authors:  Ming-Chang Hu; Orson W Moe
Journal:  Nat Rev Nephrol       Date:  2012-06-05       Impact factor: 28.314

6.  Renal Hemodynamics in AKI: In Search of New Treatment Targets.

Authors:  Martin Matejovic; Can Ince; Lakhmir S Chawla; Roland Blantz; Bruce A Molitoris; Mitchell H Rosner; Mark D Okusa; John A Kellum; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2015-10-28       Impact factor: 10.121

Review 7.  Acute kidney injury in HCT: an update.

Authors:  J A Lopes; S Jorge; M Neves
Journal:  Bone Marrow Transplant       Date:  2016-02-08       Impact factor: 5.483

Review 8.  The role of CD47 in pathogenesis and treatment of renal ischemia reperfusion injury.

Authors:  Jeffrey S Isenberg; David D Roberts
Journal:  Pediatr Nephrol       Date:  2018-11-03       Impact factor: 3.714

9.  Tissue engineering toward organ-specific regeneration and disease modeling.

Authors:  Christian Mandrycky; Kiet Phong; Ying Zheng
Journal:  MRS Commun       Date:  2017-07-31       Impact factor: 2.566

Review 10.  Emerging Kidney Models to Investigate Metabolism, Transport, and Toxicity of Drugs and Xenobiotics.

Authors:  Piyush Bajaj; Swapan K Chowdhury; Robert Yucha; Edward J Kelly; Guangqing Xiao
Journal:  Drug Metab Dispos       Date:  2018-08-03       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.